FDA Approves MORPHINE SULFATE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC announced today the U.S. approval of its generic morphine sulfate, triggering a pivotal competition opportunity for manufacturers to capitalize on high-volume oral opiate sales. The ANDA clearance is anticipated to significantly pressure the market prices of existing infusions, offering providers a cost-effective alternative for the multi-billion dollar pain management segment.